Global food business Princes, which manufactures tinned meats, pastes and ready meals, has acquired two new facilities as part of an £83 million investment.
The business announced the purchase of the Royal Liver Building (RLB) in Liverpool as part of a £60 million investment, which forms part of a broader £83 million real estate plan that also included the Symington’s Cross Green facility in Leeds for £23 million.
Princes said these acquisitions “solidified its operational and financial foundations, ensuring long-term flexibility and supporting the company’s growth strategy”. The Cross Green acquisition will reportedly provide a “stable base” for Symington’s warehousing and corporate operations.
Operating 10 sites across the country and employing almost 3,000 people, the business recently announced a campaign to “champion UK food manufacturing”, while stating that it planned to expand its presence within the Royal Liver Building to use it not only as a corporate headquarters but also as a venue for events and public engagement.
Simon Harrison, CEO of Princes, commented: “These acquisitions reflect our commitment to operational excellence, sustainable growth, and creating value for all stakeholders. By securing ownership of these operationally critical sites, we are positioning Princes for long-term success.”
Princes commented that the acquisitions will drive group revenue to €3.2 billion in 2025, which it said marked “solid progress” towards the Group’s €5 billion revenue target by 2030.
Joe Dent, chief people officer, added: “The Royal Liver Building and Cross Green aren’t just buildings; they are spaces that support the hundreds of people who drive our business forward every day. By securing ownership, we’re delivering stability and unlocking opportunities for future growth, ensuring our colleagues have the right environment to thrive in the years to come. This is a significant moment in Princes ambitions.”
Angelo Mastrolia, chairman of NewPrinces Group, said: “With these acquisitions, we’re building on a shared legacy. The Royal Liver Building will not only serve as a symbol of our ambition but also as a strategic platform for expansion, innovation, and cultural engagement.”
